Domov › CHOPN › Texas › Dallas
Klinické štúdie CHOPN v meste Dallas, TX
12 štúdií pre CHOPN hľadá účastníkov v zariadeniach v meste Dallas a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Prebieha náborFáza 3
- Research Site, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Prebieha náborFáza 3
- IntraCare- Site Number : 8400034, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Prebieha náborFáza 3
- Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Prebieha nábor
- University of Texas Southwestern, Dallas
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Prebieha náborFáza 2
- Research Site, Dallas
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Prebieha náborFáza 3
- Research Site, Dallas
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Prebieha náborFáza 2/3
- Alina Clinical Trials, LLC., Dallas
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Prebieha náborFáza 3
- GC2501 Study Site 109, Dallas
STRIVE Post-Market Registry Study
Prebieha náborObservačná štúdia
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Prebieha náborFáza 3
- GSK Investigational Site, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Prebieha náborObservačná štúdia
- Liver Center of Texas, Dallas
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Prebieha náborFáza 3
- GSK Investigational Site, Dallas
Štúdie CHOPN v iných mestách
- Philadelphia, PA23 štúdií
- Miami, FL18 štúdií
- Birmingham, AL17 štúdií
- Boston, MA17 štúdií
- Houston, TX15 štúdií
- Orlando, FL15 štúdií
- Baltimore, MD14 štúdií
- Chicago, IL14 štúdií
- Pittsburgh, PA12 štúdií
- New York City, NY11 štúdií
- Ann Arbor, MI10 štúdií
- Winston-Salem, NC9 štúdií
Iné štúdie v Dallas
- Rakovina prsníka55 štúdií
- Nemalobunkový karcinóm pľúc52 štúdií
- Metastatická rakovina42 štúdií
- Srdcové zlyhanie42 štúdií
- Rakovina (všetky typy)37 štúdií
- Rakovina prostaty36 štúdií
- Kolorektálny karcinóm33 štúdií
- Obézita30 štúdií
- Rakovina vaječníkov28 štúdií
- Rakovina močového mechúra27 štúdií
- Rakovina pľúc27 štúdií
- Rakovina endometria24 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.